跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,609 条关于
“IL-2Ralpha”
全部
5,609
临床试验
3,011
药物
1,147
机构
32
资讯
1,419
前天
FDA approves Mesoblast's new potency assay for commercial Ryoncil release
去年
Landmark Clinical Trials Demonstrate Efficacy of IL-13 and IL-4/IL-13 Inhibitors in Patients with Darker Skin Tones
去年
Medicenna Secures Five New Patents for IL-2 and IL-4 Superkine Immunotherapies
2年前
Medicenna Presents Preclinical Data on IL-2 Super-Antagonist MDNA209 and Anti-PD1-IL-2 BiSKIT MDNA113
去年
IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients
9天前
Aethlon and North Immunology Merge to Advance IL-13 x IL-18 Bispecific Antibody NOR-101 for Atopic Dermatitis
8个月前
Turn Therapeutics Advances Phase 2 Atopic Dermatitis Trial with First-in-Class IL-36/IL-31 Inhibitor GX-03
10个月前
Mabwell's Anti-IL-11 Antibody 9MW3811 Becomes World's First IL-11 Therapeutic to Enter Phase II for Pathological Scarring
上个月
Infinimmune Raises $75M Series A to Advance IL-22 and IL-13 Antibodies for Atopic Dermatitis Toward 2027 Clinical Entry
去年
Werewolf Therapeutics Announces 2025 Milestones for IL-2 and IL-12 INDUKINE Programs
第 1 页,共 142 页
上一页
下一页